tiprankstipranks
Denali Therapeutics (DNLI)
NASDAQ:DNLI
Holding DNLI?
Track your performance easily

Denali Therapeutics (DNLI) Financial Statements

623 Followers

Denali Therapeutics Financial Overview

Denali Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.764; its P/E ratio is -8.76; Denali Therapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue---$ 294.12M$ 35.14M
Gross Profit---$ 294.12M$ 35.14M
EBIT$ -123.19M$ -116.59M$ -132.57M$ 170.48M$ -109.78M
EBITDA$ -129.73M$ -114.65M$ -130.40M$ 172.77M$ -99.73M
Net Income Common Stockholders$ -107.19M$ -99.03M$ -119.47M$ 183.38M$ -109.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 836.56M$ 896.04M$ 1.03B$ 1.19B$ 1.29B
Total Assets$ 1.45B$ 1.50B$ 1.15B$ 1.31B$ 1.41B
Total Debt$ 52.52M$ 48.75M$ 44.98M$ 55.52M$ 57.09M
Net Debt$ -784.04M$ -847.29M$ -989.53M$ -1.14B$ -1.23B
Total Liabilities$ 135.52M$ 115.48M$ 122.96M$ 118.91M$ 442.64M
Stockholders Equity$ 1.32B$ 1.39B$ 1.03B$ 1.19B$ 966.71M
Cash Flow-
Free Cash Flow$ -63.02M$ -96.01M$ -100.89M$ -119.02M$ -61.59M
Operating Cash Flow$ -59.14M$ -91.22M$ -98.66M$ -113.17M$ -58.80M
Investing Cash Flow$ 93.66M$ 98.57M$ 73.05M$ 168.07M$ -92.72M
Financing Cash Flow$ -18.56M$ 6.76M$ 4.71M$ 9.02M$ 1.60M
Currency in USD

Denali Therapeutics Earnings and Revenue History

Denali Therapeutics Debt to Assets

Denali Therapeutics Cash Flow

Denali Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis